Cardiology – Page 3

Evaluating the Impact of the Resuscitation Quality Improvement Program on In-Hospital Cardiac Arrest Outcomes

By MedXY 07/12/2026

A national cohort study found that adoption of the Resuscitation Quality Improvement (RQI) program for CPR training did not improve survival to discharge or return of spontaneous circulation in patients experiencing in-hospital cardiac arrest, highlighting the need for more comprehensive strategies.

Cardiology news

Assessing Cardiovascular Risk in First-Degree Relatives of Individuals with Elevated Lipoprotein(a): Insights from a Swedish Cohort Study

By MedXY 07/12/2026

A cohort study demonstrates increased major cardiovascular event risk in first-degree relatives of individuals with high plasma lipoprotein(a), supporting cascade screening for targeted prevention.

Cardiology news Public Health

Unraveling Cardiovascular Health Improvements Post-Antihypertensive Intervention: Insights from the CRHCP Trial

By MedXY 07/12/2026

This analysis of the China Rural Hypertension Control Project reveals that intensive blood pressure management chiefly drives cardiovascular risk reduction, with modest contributions from behavioral and metabolic changes, highlighting domain-specific intervention effects.

Cardiology news

Clinical Diagnosis of Calcium Release Deficiency Syndrome in a Family With Sudden Cardiac Death

By MedXY 07/10/2026

A 5-generation French Canadian family with history of sudden cardiac death was diagnosed with calcium release deficiency syndrome using a novel burst pacing provocation test, illustrating its clinical utility and highlighting the importance of pause-dependent arrhythmia detection.

Cardiology news

Risk-weighted apoB: A Superior Predictor of Coronary Heart Disease Risk Beyond Traditional Lipid Measures

By MedXY 07/09/2026

Risk-weighted apoB (RW-apoB) integrates LDL, TRL/remnants, and Lp(a) atherogenicity to improve coronary heart disease risk prediction, outperforming conventional lipid biomarkers like apoB and LDL-C in multiple population cohorts including statin-treated patients.

Cardiology news

Unveiling the Natural History of Asymptomatic Mild Hypertrophic Cardiomyopathy: Insights from the SHaRe Registry

By MedXY 07/09/2026

This study reveals that 21% of asymptomatic patients with mild HCM develop major adverse cardiovascular events over 7 years, highlighting key predictors such as age, symptom progression, and cardiac remodeling markers that inform management and future therapies.

Cardiology news

Obicetrapib’s Impact on Lipoprotein(a) in High Cardiovascular Risk Patients: A Comprehensive Pooled Analysis

By MedXY 07/07/2026

Obicetrapib significantly lowers lipoprotein(a), LDL cholesterol, and apolipoprotein B in high cardiovascular risk patients, offering a promising addition to lipid-lowering therapies, especially for patients with mild to moderate Lp(a) elevation.

Cardiology news

Sirolimus-Eluting Balloons in Coronary In-Stent Restenosis: Comparative Efficacy Against Repeat DES and Balloon Angioplasty

By MedXY 07/07/2026

The SELUTION4ISR trial demonstrates that sirolimus-eluting balloons are a safe and effective noninferior alternative to standard care, including repeat drug-eluting stents, for treating coronary in-stent restenosis at 1 year.

Cardiology Critical Care news

Identifying Cardiovascular Subphenotypes in Sepsis: Toward Personalized Hemodynamic Management

By MedXY 07/07/2026

Unsupervised clustering of echocardiographic and hemodynamic data in sepsis reveals four distinct cardiovascular subphenotypes, each with unique mortality risks and responses to treatment, enabling personalized shock management strategies.

Cardiology news Respiratory

Impact of Short-Term High-Altitude Exposure on Right Ventricular Load and Oxygen Delivery in Pulmonary Vascular Disease Patients

By MedXY 07/05/2026

A two-day stay at 2500 m altitude increases right ventricular afterload and impairs ventricular-arterial coupling but maintains oxygen delivery in stable pulmonary vascular disease patients.

Cardiology Clinical Updates Family Medicine & Nutrition news

Two Years of Menaquinone-7 Supplementation Attenuates Coronary Artery Calcification Progression: Evidence from Randomized Clinical Trials

By MedXY 07/04/2026

Menaquinone-7 (MK-7) supplementation over two years significantly slows progression of coronary artery calcification (CAC) in symptomatic coronary artery disease patients, with favorable safety and potential implications for plaque stabilization.

Cardiology news

Reducing Procedure Time with CT-Guided Catheter Ablation in Ventricular Tachycardia: Insights from the InEurHeart Trial

By MedXY 07/04/2026

The InEurHeart trial demonstrates that computed tomography-guided ventricular tachycardia ablation significantly reduces procedure duration while maintaining safety and efficacy compared to conventional methods in patients with ischemic cardiomyopathy.

Cardiology news Radiology

Harnessing Cardiac CT Radiomics of Epicardial Fat for Early Heart Failure Prediction

By MedXY 07/04/2026

Radiomic analysis of epicardial adipose tissue from routine cardiac CT scans enables robust, noninvasive early prediction of heart failure risk, enhancing conventional models and supporting precision prevention strategies.

Cardiology Clinical Updates news

Impact of Cerebral Small Vessel Disease on Functional Decline: Insights from the Bleeding With Antithrombotic Therapy 2 Study and Related Evidence

By MedXY 07/03/2026

Cerebral small vessel disease (SVD) significantly contributes to functional decline independently of bleeding or ischemic events during antithrombotic therapy, underscoring the need for targeted management strategies to address SVD burden in cerebrovascular patients.

Cardiology Nephrology news

Acoramidis and Kidney Function in Transthyretin Amyloid Cardiomyopathy: Clinical Implications and Hemodynamic Insights

By MedXY 07/03/2026

Acoramidis stabilizes transthyretin and shows kidney-protective effects in transthyretin amyloid cardiomyopathy by reducing eGFR decline and albuminuria, with an initial reversible dip in kidney function associated with improved clinical outcomes.

Cardiology Clinical Updates news

Economic Impact and Clinical Benefits of Quadruple Guideline-Directed Medical Therapy in Heart Failure with Reduced Ejection Fraction: A Comprehensive Review

By MedXY 07/03/2026

This review synthesizes evidence demonstrating that implementing full quadruple GDMT (ARNI, β-blockers, MRAs, SGLT2i) in HFrEF reduces hospitalization risks and healthcare costs, often yielding net savings despite medication expenses.

Cardiology news Respiratory

Enhancing Risk Prediction After TAVI: The COPD-Augmented R₂CHA₂DS₂-VA Score and Its Prognostic Value

By MedXY 07/03/2026

A novel risk score incorporating COPD and graded renal dysfunction improves prediction of one-year mortality post-TAVI, showing excellent internal validity but requiring external validation before clinical use.

Cardiology Clinical Updates Internal Medicine news

Switching from Warfarin to Direct Oral Anticoagulants in Frail Elderly Asian Patients with Atrial Fibrillation: Insights from a Korean Nationwide Study

By MedXY 07/03/2026

In frail elderly Asian AF patients stable on warfarin, transitioning to DOACs increased risks of bleeding, thromboembolic events, and mortality, emphasizing cautious individualized management.

Cardiology Diabetes & Endocrinology news

Ultra-Thin Sirolimus-Eluting Stents Show Noninferiority to Everolimus-Eluting Stents in Diabetic Multivessel CAD: Insights from TUXEDO-2 Trial

By MedXY 07/02/2026

The TUXEDO-2 trial demonstrated that ultra-thin strut biodegradable polymer sirolimus-eluting stents are noninferior to durable polymer everolimus-eluting stents in diabetic patients with multivessel coronary artery disease at 1-year follow-up.

Cardiology news

Impact of Multidimensional Social Adversity on Mortality and Rehospitalization in People with HIV and Heart Failure

By MedXY 07/02/2026

This study explores how various social adversity domains affect mortality and rehospitalization risks in HIV-positive patients with heart failure, underscoring the importance of holistic social assessments for improving outcomes.